Analytical factors for optimization of chain-length distribution analysis of mRNA using capillary gel electrophoresis
Journal of Chromatography A · 2025
DOI: 10.1016/j.chroma.2025.466019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chromatography A, 2025. Verfasst von Takenori Yamamoto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagaw…. Hauptthemen laut MEDLINE: RNA, Messenger. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
The development of mRNA vaccines against coronavirus disease-2019 has garnered attention in utilizing mRNA-based modalities such as mRNA vaccines and therapeutics. mRNA length is a crucial factor in the quality assessment of mRNA-based modalities, confirming the integrity of mRNA as an active component. Capillary gel electrophoresis is a representative analytical method used to examine mRNA chain length and should sufficiently separate full-length mRNAs and impurity RNAs (shortmers and longmers) to accurately evaluate mRNA quality. However, the analytical parameters affecting the separation of mRNAs have not been adequately verified. This study comprehensively analyzed the analytical parameters of capillary gel electrophoresis, and found that the gel concentration, denaturant, preheating treatment, capillary temperature, and fluorescent dye remarkably affect the separation of long-chain-length RNAs. The separation limits of capillary gel electrophoresis analysis were examined under adjusted analytical parameter conditions. Consequently, RNAs of approximately 4,000 nucleotides length and their defective RNAs of ≥200 nucleotides could be effectively separated. Furthermore, when RNA separation under our adjusted conditions was compared with that under the conditions recommended in the United States Pharmacopeia (USP) draft guidelines, our method demonstrated higher RNA separation for both RNA prepared in this study and that of the approved mRNA vaccine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa, 210-9501, Japan. Electronic address: tyamamoto@nihs.go.jp.
- Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa, 210-9501, Japan.
- Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa, 210-9501, Japan. Electronic address: takao@nihs.go.jp.
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Yamamoto, T., Yoshida, T., Uchida, Y., Ohoka, N., Yamashita, T., Uchida, E., & Inoue, T. (2025). Analytical factors for optimization of chain-length distribution analysis of mRNA using capillary gel electrophoresis. Journal of Chromatography A. https://doi.org/10.1016/j.chroma.2025.466019
Vancouver
Yamamoto T, Yoshida T, Uchida Y, Ohoka N, Yamashita T, Uchida E, et al. Analytical factors for optimization of chain-length distribution analysis of mRNA using capillary gel electrophoresis. Journal of Chromatography A. 2025. doi:10.1016/j.chroma.2025.466019
BibTeX
@article{Yamamoto2025,
author = {Yamamoto, Takenori and Yoshida, Tokuyuki and Uchida, Yasunori and Ohoka, Nobumichi and Yamashita, Takuma and Uchida, Eriko and Inoue, Takao},
title = {Analytical factors for optimization of chain-length distribution analysis of mRNA using capillary gel electrophoresis},
journal = {Journal of Chromatography A},
year = {2025},
doi = {10.1016/j.chroma.2025.466019}
}
EUVIMED